Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
General vs Combined Spinal-epidural Anesthesia for TCIC
NCT03636048Terminated
- Sponsor
- Hallym University Kangnam Sacred Heart Hospital
- Start
- Aug 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in Cervical insufficiency (CI) (2 arms), sponsored by Hallym University Kangnam Sacred Heart Hospital. Primary endpoint: Postoperative Pain Score at 24 hours. Started Aug 2018; status: terminated.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
Cervical insufficiency (CI)
Beyond the preview
Go deeper on NCT03636048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03636048.